Artios Pharma Limited’s US$153 Million Series C Financing

Federica Tiefenthaler
Tagged:

Goodwin Procter advised Omega Funds on the deal.Artios Pharma Limited (Artios), a leading DNA Damage Response (DDR) company exploiting a broad DDR-based platform and small molecule…

This content is for Standard 1 Year members only.
Login Join Now
Federica Tiefenthaler

Author: Federica Tiefenthaler

…

This content is for Standard 1 Year members only.
Login Join Now